JP4763617B2 - デスモプレシンの固形製剤の製造方法 - Google Patents
デスモプレシンの固形製剤の製造方法 Download PDFInfo
- Publication number
- JP4763617B2 JP4763617B2 JP2006546099A JP2006546099A JP4763617B2 JP 4763617 B2 JP4763617 B2 JP 4763617B2 JP 2006546099 A JP2006546099 A JP 2006546099A JP 2006546099 A JP2006546099 A JP 2006546099A JP 4763617 B2 JP4763617 B2 JP 4763617B2
- Authority
- JP
- Japan
- Prior art keywords
- desmopressin
- starch
- air flow
- flow rate
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
i)少なくとも1種の賦形剤、キャリヤーもしくは希釈剤、又はその混合物を含有するか、又はこれらから構成される粉末を提供する段階と;
ii)溶媒とデスモプレシン、又は医薬的に許容可能なその塩と、場合により結合剤を含有する造粒液を提供する段階と;
iii)前記装置の内側で前記造粒液を好ましくは噴霧により前記粉末と接触させる段階を含む工程により製造され、前記混合剪断作用を提供するように流動化空気流量と処理温度及び時間を同時に調節し、場合により、前記接触の完了後にも調節する。
乳糖(900g,Pharmatose 150M;DMV,NL製品)とジャガイモ澱粉(550g,AmylSolVat;Lyckeby Starkelse AB,SE製品)をプラネタリーミキサーで15分間室温で混合し、1mmシーブで篩分けした。水(75ml)とPVP(13.8g,Kollidon(登録商標)25;BASF GmbH,DE製品)から構成される造粒液を調製し、これに酢酸デスモプレシン(0.75g;PolyPeptide Laboratories AB,SE製品)とエタノール(225g)を加えた。次に20分間混合下に造粒液を乳糖/澱粉混合物に徐々に加えた後、更に10分間室温で混合した。篩分け(1.4mm)し、約20時間40℃で乾燥し、更に篩分け(1.4mm)した後、得られた粒状体をステアリン酸マグネシウム(11.3g,1.0mm篩分け;Peter Greven NV,NL製品)と混合した後、シングルパンチ打錠機(Fette Exacta 1)を使用して7500錠に打錠した。製造された典型的な商業用錠剤は酢酸デスモプレシン0.1mgを含有しており、厚さ3〜4mm及び目標重量192mgの白色凸状卵形(6.8×9.6mm)であった。表面は滑らかで引っ掻き傷や縁部の破損がなく、ラミネーション(所謂キャッピング)傾向もなかった。
乳糖(476.6g,Granulac 140;Meggle AG,DE製品)とジャガイモ澱粉(294.6g,M14;KMC,DK製品)を流動層造粒装置(Strea 1;Aeromatic Fielder AG,DE製品)に装入し、設定温度45℃で25m3/hの上向き流動化空気流量下に2分間混合した。PVP(24g,Povidone;BASF,DE製品)と酢酸デスモプレシン(0.80g;PolyPeptide Laboratories AB,SE製品)を水(80g)に溶かすことにより造粒液を調製した。次に、温度45℃で25m3/hの上向き流動化空気流量下におきながら、乳糖/澱粉混合物に造粒液を一定速度で15分間下向きに噴霧した。全造粒液を加えたら、同一空気流量と温度を更に20分間維持した。得られた乾燥粒状体を次に篩分け(1.0mm)し、慣用ミキサー(AR400E;EWREKA GmbH,DE製品)で粉末ステアリン酸マグネシウム(4g,1.0mm篩分け;Peter Greven NV,NL製品)と2分間混合した後、目標重量を200mgとしてロータリーパンチ(φ8mm)打錠機(Korsch XL100;Korsch,DE製品)で4000錠に打錠した。こうして各々酢酸デスモプレシン0.2mgを含有する硬度5kp(1kp=9.81N)の錠剤を製造した。錠剤は表面が滑らかで引っ掻き傷や縁部の破損がなく、キャッピングも認められなかった。
PVP含有率(合計の%w/w)を変化させ、ジャガイモ澱粉(KMC M14)の代わりにコーンスターチ(白トウモロコシ澱粉,C(star)PharmGel 03302;Cerestar Benelux B.V.)又は微結晶セルロース(Avicel(登録商標)PH 102;FMC BioPolymer)を使用した以外は実施例2に従って錠剤を製造した。以下の5種類の錠剤を比較し、図1に示す。
Potato 1% PVP(ジャガイモ澱粉)
Microcryst 1% PVP(Avicel(登録商標))
Corn 1% PVP(コーンスターチ)
Microcryst 0% PVP(Avicel(登録商標))
Corn 0% PVP(コーンスターチ)
錠剤を人工気象室に入れ、40℃、相対湿度(RH)75%で保存した。無傷デスモプレシン(0カ月の出発時含有率100%)の含有率を経時的にモニターし、結果を図1にまとめた。各種錠剤20錠を試験し、平均値を示した。デスモプレシン含有率は従来の液体クロマトグラフィーとUVスペクトロスコピー(220nm)によりモニターした。総括すると、流動層造粒により得られたデスモプレシン錠剤で最も安定していたのは意外にもコーンスターチを使用した場合であった。
Claims (16)
- デスモプレシン又は医薬的に許容可能なその塩の固形製剤の製造方法であって、前記デスモプレシン又は医薬的に許容可能なその塩と少なくとも澱粉を流動層造粒装置で造粒する工程を含み、得られたデスモプレシン含有粒状体が医薬的に許容可能な錠剤に打錠するのに適しており、かつ粒状体は結合剤としてPVPを含む、前記方法。
- 水を単独溶媒として含有する造粒液を使用する請求項1に記載の方法。
- 前記粒状体の製造工程が流動化空気流量と処理温度及び時間を調節することを含む請求項1から2のいずれか一項に記載の方法。
- 前記デスモプレシンを含有する粒状体が、
i)少なくとも澱粉を含有する粉末を提供する段階と;
ii)溶媒とデスモプレシン、又は医薬的に許容可能なその塩と、場合により結合剤を含有する造粒液を提供する段階と;
iii)前記装置の内側で前記造粒液を前記粉末と接触させる段階を含む工程により製造され、混合剪断作用を提供するように流動化空気流量と処理温度及び時間を同時に調節する請求項3に記載の方法。 - 前記溶媒が水である請求項4に記載の方法。
- 前記流動化空気流量が10〜2500m3/hである請求項3から5のいずれか一項に記載の方法。
- 前記流動化空気流量が20〜1500m3/hである請求項6に記載の方法。
- 前記処理温度が25〜80℃である請求項3から7のいずれか一項に記載の方法。
- 前記処理温度が30〜60℃である請求項8に記載の方法。
- 前記処理時間が10〜240分間である請求項3から9のいずれか一項に記載の方法。
- 前記澱粉がコーンスターチである請求項1から10のいずれか一項に記載の方法。
- 前記デスモプレシンを含有する粒状体を打錠する請求項1から11のいずれか一項に記載の方法。
- 打錠前に滑沢剤を前記粒状体に添加する請求項12に記載の方法。
- 前記滑沢剤がステアリン酸マグネシウムである請求項13に記載の方法。
- 前記固形製剤が腸溶コーティングをもたない請求項1から14のいずれか一項に記載の方法。
- 前記固形製剤がpH2〜6の緩衝能をもつ物質を含まない請求項1から15のいずれか一項に記載の方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/746,254 US7018653B2 (en) | 2003-12-29 | 2003-12-29 | Method for preparing solid dosage form of desmopressin |
US10/746,254 | 2003-12-29 | ||
EP03029897.0 | 2003-12-29 | ||
EP03029897A EP1550439B1 (en) | 2003-12-29 | 2003-12-29 | Method for preparing a solid dosage form of desmopressin |
PCT/EP2004/014781 WO2005063202A2 (en) | 2003-12-29 | 2004-12-28 | Method for preparing solid dosage form of desmopressin |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007517000A JP2007517000A (ja) | 2007-06-28 |
JP4763617B2 true JP4763617B2 (ja) | 2011-08-31 |
Family
ID=34702338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006546099A Active JP4763617B2 (ja) | 2003-12-29 | 2004-12-28 | デスモプレシンの固形製剤の製造方法 |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1699437B1 (ja) |
JP (1) | JP4763617B2 (ja) |
KR (1) | KR100870679B1 (ja) |
AU (1) | AU2004308670B2 (ja) |
BR (1) | BRPI0418240A (ja) |
CA (1) | CA2490601C (ja) |
DE (1) | DE602004010302T2 (ja) |
DK (1) | DK1699437T3 (ja) |
ES (1) | ES2295962T3 (ja) |
MX (1) | MXPA06007507A (ja) |
NZ (1) | NZ546817A (ja) |
PL (1) | PL209823B1 (ja) |
RU (1) | RU2334505C2 (ja) |
WO (1) | WO2005063202A2 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000204045A (ja) * | 1999-01-11 | 2000-07-25 | Calpis Co Ltd | 造粒物、その製法及びこれを用いた錠剤 |
JP2002538097A (ja) * | 1999-03-03 | 2002-11-12 | イーライ リリー アンド カンパニー | 薬学的経口ecb処方物および組成物の作製方法 |
WO2003094886A2 (en) * | 2002-05-07 | 2003-11-20 | Ferring Bv | Desmopressin in an orodispersible dosage form |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995018602A1 (en) * | 1994-01-11 | 1995-07-13 | Alkermes Controlled Therapeutics, Inc. | ORAL DOSAGE FORM OF DESMOPRESSIN (dDAVP) |
PL367957A1 (en) * | 2001-10-15 | 2005-03-07 | Röhm Gmbh & Co.Kg | Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent |
EP1473029B1 (en) * | 2003-04-30 | 2005-03-23 | Ferring B.V. | Solid dosage form comprising desmopressin |
ES2243840T3 (es) * | 2003-07-25 | 2005-12-01 | Ferring B.V. | Composicion farmaceutica de desmopresina como forma farmaceutica solida de dosificacion y metodo para la fabricacion de la misma. |
-
2004
- 2004-12-20 CA CA002490601A patent/CA2490601C/en not_active Expired - Fee Related
- 2004-12-28 AU AU2004308670A patent/AU2004308670B2/en not_active Ceased
- 2004-12-28 PL PL381356A patent/PL209823B1/pl not_active IP Right Cessation
- 2004-12-28 JP JP2006546099A patent/JP4763617B2/ja active Active
- 2004-12-28 RU RU2006120954/15A patent/RU2334505C2/ru not_active IP Right Cessation
- 2004-12-28 EP EP04804367A patent/EP1699437B1/en active Active
- 2004-12-28 KR KR1020067011662A patent/KR100870679B1/ko not_active IP Right Cessation
- 2004-12-28 MX MXPA06007507A patent/MXPA06007507A/es active IP Right Grant
- 2004-12-28 DK DK04804367T patent/DK1699437T3/da active
- 2004-12-28 DE DE602004010302T patent/DE602004010302T2/de active Active
- 2004-12-28 NZ NZ546817A patent/NZ546817A/en not_active IP Right Cessation
- 2004-12-28 WO PCT/EP2004/014781 patent/WO2005063202A2/en active IP Right Grant
- 2004-12-28 ES ES04804367T patent/ES2295962T3/es active Active
- 2004-12-28 BR BRPI0418240-5A patent/BRPI0418240A/pt not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000204045A (ja) * | 1999-01-11 | 2000-07-25 | Calpis Co Ltd | 造粒物、その製法及びこれを用いた錠剤 |
JP2002538097A (ja) * | 1999-03-03 | 2002-11-12 | イーライ リリー アンド カンパニー | 薬学的経口ecb処方物および組成物の作製方法 |
WO2003094886A2 (en) * | 2002-05-07 | 2003-11-20 | Ferring Bv | Desmopressin in an orodispersible dosage form |
Also Published As
Publication number | Publication date |
---|---|
PL209823B1 (pl) | 2011-10-31 |
RU2006120954A (ru) | 2008-02-10 |
AU2004308670A1 (en) | 2005-07-14 |
PL381356A1 (pl) | 2007-05-28 |
DK1699437T3 (da) | 2007-12-27 |
WO2005063202A2 (en) | 2005-07-14 |
KR20060111566A (ko) | 2006-10-27 |
MXPA06007507A (es) | 2007-01-30 |
WO2005063202A3 (en) | 2006-05-18 |
RU2334505C2 (ru) | 2008-09-27 |
EP1699437B1 (en) | 2007-11-21 |
KR100870679B1 (ko) | 2008-11-26 |
CA2490601C (en) | 2006-05-02 |
DE602004010302D1 (de) | 2008-01-03 |
EP1699437A2 (en) | 2006-09-13 |
AU2004308670B2 (en) | 2007-08-02 |
BRPI0418240A (pt) | 2007-04-17 |
ES2295962T3 (es) | 2008-04-16 |
DE602004010302T2 (de) | 2008-10-16 |
CA2490601A1 (en) | 2005-06-29 |
JP2007517000A (ja) | 2007-06-28 |
NZ546817A (en) | 2010-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101524164B1 (ko) | 방출 제어 의약 조성물 | |
JP6173521B2 (ja) | ナルブフィンを含有する製剤及びそれらの使用 | |
ZA200605262B (en) | Method for preparing solid dosage form of desmopressin | |
JP4868695B2 (ja) | 崩壊性が良好な経口製剤 | |
EP2921170A1 (en) | Combination immediate release controlled release levodopa/carbidopa dosage forms | |
EP3437646A1 (en) | Oral preparation having exceptional elutability | |
EP3130355A1 (en) | Pharmaceutical composition containing pregabalin with improved stability and method for preparing same | |
US20130022683A1 (en) | Method for improving dissolution of anticoagulant agent | |
WO2012101653A2 (en) | Modified release pharmaceutical compositions memantine | |
EP2554169A1 (en) | Pharmaceutical preparation comprising phenylalanine derivative | |
KR20090092288A (ko) | 뉴로키닌 길항제를 포함하는 제약 제형 | |
CA2860098A1 (en) | Immediate release multi unit pellet system | |
JP2016188181A (ja) | ミラベグロン含有放出制御錠剤 | |
JP2009528312A (ja) | デスモプレシンを含む組成物 | |
RU2303439C2 (ru) | Фармацевтическая композиция десмопрессина в виде твердой дозированной лекарственной формы и способ ее изготовления | |
EP2814465B1 (en) | Pharmaceutical formulation having improved stability | |
TWI282284B (en) | Method for preparing solid dosage form of desmopressin | |
JP4763617B2 (ja) | デスモプレシンの固形製剤の製造方法 | |
KR20140146095A (ko) | 여드름의 치료 방법 | |
KR20110071104A (ko) | 경구 투여용 의약 조성물 | |
HU215191B (hu) | Eljárás Levodopa és Carbidopa hatóanyag-kombinációt tartalmazó, szabályozott hatóanyag-leadású, központi dopaminhiányos állapotok kezeléséhez alkalmas orális gyógyszerkészítmény előállítására |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20090713 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20090724 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100608 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100908 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101005 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110204 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110331 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20110404 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20110426 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110524 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110609 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140617 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4763617 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |